奥瑞克制药 ORIC
$8.82 +$0.33 (+3.89%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.82 0.00%
开盘$8.61
昨收$8.49
当日区间$8.50 – $8.93
成交量556.7K
市值$914.22M
市盈率（TTM）–
股息率–
ORIC 相关新闻
匹配 Oric Pharmaceuticals 或代码 ORIC 的头条新闻，按最新排序。
- BTIG Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $26
- J.P. Morgan Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $23
- A Quick Look at Today's Ratings for Oric Pharmaceuticals(ORIC.US), With a Forecast Between $14 to $25
- H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Raises Target Price to $27 正面
- HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $27 正面
- HC Wainwright & Co. Reiterates Buy on ORIC Pharmaceuticals, Maintains $25 Price Target
- Goldman Sachs Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $15
- Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Tactile Systems Technology (TCMD) and Oric Pharmaceuticals (ORIC)
- Piper Sandler Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $22
- H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $25
- Stifel Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $14
- Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $14
- Wells Fargo Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $25
- Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $15
- Goldman Sachs Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating
暂无评论——快来第一个聊聊 ORIC。
登录后参与讨论。